) [153]. This technique is presently not scalable since it relies on costly startup substrates which may be employed to supply psilocybin in less expensive chemical synthesis methodologies. A methodology for de novo production of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,The standard urine drug screening for employment would